The recent Teleflex update centers on a refreshed fair value estimate, which has shifted from about US$124.14 to about US$129.25 as analysts tweak their models for revenue growth and the discount rate ...

This medical device firm supplies hospitals worldwide with single-use products for critical care, surgery, and interventional procedures.

Teleflex is splitting its business into two independently traded entities, with a completion date set for mid-2026. The ...

The latest announcement is out from Teleflex ( (TFX) ).

Teleflex is selling its acute care, interventional urology, and original equipment manufacturer (OEM) businesses in two separate deals totalling over $2bn as part of the company’s broader portfolio ...

Teleflex (TFX) has agreed to sell its acute care, interventional urology and OEM businesses to two buyers for a combined $2.03 billion in cash, subject to adjustments. Intersurgical will acquire the ...

Shares of Teleflex Inc. TFX slid 2.25% to $104.54 Thursday, on what proved to be an all-around poor trading session for the ...

Teleflex Incorporated presented new clinical data at the 2025 American Urological Association Annual Meeting, highlighting the UroLift™ System as a leading minimally invasive treatment for benign ...

Teleflex is inking a $650 million deal to acquire Palette Life Sciences, the maker of urologic spacer implants and tissue bulking products. The agreement includes $600 million in upfront cash, plus ...

Teleflex Incorporated (NYSE:TFX) reported better-than-expected earnings for the third quarter on Thursday. The company posted quarterly earnings of $3.67 per share which beat the analyst consensus ...